Soleno Therapeutics (SLNO) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.45
-0.04
0.38
0.8

Details

Expected EPS
0.68
Actual EPS
0.59
Surprise EPS
-0.09
Surprise Percent
+13.24%

Description

Soleno Therapeutics (SLNO) has reported earnings of 0.59 per share for Q2 2026.

0 Comments

Share your thoughts